ArticleCureus2026
Hepatic Candidiasis in a Non-neutropenic Patient.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic candidiasis is an uncommon but serious manifestation of invasive candidiasis (IC), most often associated with prolonged neutropenia in patients with hematological malignancies or in those who have undergone abdominal surgery. Diagnosis is challenging because of the low sensitivity of cultures, the limitations of serologic assays, and the frequent impracticality of tissue biopsy. Imaging, particularly CT and [18F]fluoro-2-deoxy-D-glucose positron emission tomography (18FDG-PET), plays a central role in identifying characteristic hepatosplenic lesions and in monitoring response to therapy. We present a case of hepatic candidiasis in a non-neutropenic patient presenting with persistent fever and multiple risk factors for IC, highlighting the diagnostic complexity and the importance of maintaining clinical suspicion beyond the classical neutropenic setting. Management requires prompt initiation of appropriate antifungal therapy, thorough evaluation for secondary foci of infection, and prolonged treatment until complete radiologic resolution is achieved to prevent relapse. Current recommendations for the management of deep-seated candidiasis remain largely based on retrospective data and expert opinion. Further research is needed to optimize diagnostic strategies, define the role of molecular diagnostic techniques, and identify patients with underlying genetic susceptibilities that may predispose them to invasive disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.